Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Mahindra Lifespace Developers’ Q1 FY27 results are expected in July-August 2026, with revenue estimated at ₹15-17 crore and PAT projected at ₹67-85 crore.
Windlas Biotech reported FY26 revenue of ₹904 crore with 19% growth, outlined segment performance, plant milestones, liquidity, and a proposed final dividend of ₹6.30 per share.
Bliss GVS Pharma’s independent directors recommended Anupam Rasayan’s ₹299 per share open offer for 26%, even as the stock traded well above the offer price.
Mphasis will hold its 35th AGM on 23 July 2026 via VC to vote on a ₹62 final dividend, director appointments, and management re-appointments after FY26 growth.
Ujjivan Small Finance Bank reported Q1 FY27 profit growth, record NII and improving asset quality, while deposits and the secured loan mix expanded and the stock turned positive after results.
Solara Active Pharma approved Q1 FY27 results on July 23, 2026, reporting revenue of ₹384.3 crore, EBITDA of ₹63.5 crore and PAT of ₹16.3 crore in its update.
Chennai Petroleum reported Q1 FY27 profit growth on higher revenue and throughput, while also announcing a ₹54 per share dividend with an August 2026 record date.
Solara Active Pharma approved Q1 FY27 results, reporting revenue of ₹384.3 crore and PAT of ₹16.3 crore, with an analyst call scheduled to discuss margins and Ibuprofen.
IRB InvIT Fund (IRBN) announced a Rs 116.10 crore Q1FY26 distribution at Rs 2 per unit, alongside modest YoY growth in toll and total income.
Oswal Overseas paid ₹2.80 crore to settle L H Sugar Factories’ claim, prompting NCLAT to let its appeal be withdrawn while Section 12A withdrawal remains pending.
Social media and analyst chatter is centred on Nifty’s 23,800 pivot, with traders tracking 23,930-24,000 for recovery and 23,550-23,100 as downside zones.
Brand Finance’s India 100 Report 2026 keeps Tata on top, flags Adani’s first top-10 entry, and shows year-on-year gains across banks, IT, and telecom.
Tirupati Innovar has lined up a May 2026 rights issue and a June–July 2026 postal ballot for a 1:10 stock split and 5:8 bonus issue, following earlier approvals for a ₹99 crore QIP and rebranding.
Vishal Mega Mart reported Q1 FY27 profit growth of 25.6% on 18.7% higher revenue, added 27 stores, capped foreign ownership at 49.99%, and saw its stock fall nearly 2% intraday.
PVR INOX said CEO-Growth & Investment Pramod Arora resigned for personal reasons effective May 24, 2026, with the exit disclosed under SEBI Regulation 30.
TTK Healthcare told the market it has not signed or executed any ₹250 crore pharma acquisition deal, asking investors to ignore reports claiming otherwise.